BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 12120224)

  • 21. The SPINK1 N34S mutation is not associated with Type 2 diabetes mellitus in a population of the USA.
    Schneider A; Lawrence EC; Barmada MM; Norris JM; Hamman RF; Marshall JA; Ferrell RE; Whitcomb DC
    Diabet Med; 2005 Jun; 22(6):744-8. PubMed ID: 15910626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characterization of patients with idiopathic chronic pancreatitis and SPINK1 Mutations.
    Schneider A; Barmada MM; Slivka A; Martin JA; Whitcomb DC
    Scand J Gastroenterol; 2004 Sep; 39(9):903-4. PubMed ID: 15513391
    [No Abstract]   [Full Text] [Related]  

  • 23. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene.
    Hirota M; Kuwata K; Ohmuraya M; Ogawa M
    JOP; 2003 Mar; 4(2):83-8. PubMed ID: 12629264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis.
    Chandak GR; Idris MM; Reddy DN; Bhaskar S; Sriram PV; Singh L
    J Med Genet; 2002 May; 39(5):347-51. PubMed ID: 12011155
    [No Abstract]   [Full Text] [Related]  

  • 26. SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh.
    Schneider A; Suman A; Rossi L; Barmada MM; Beglinger C; Parvin S; Sattar S; Ali L; Khan AK; Gyr N; Whitcomb DC
    Gastroenterology; 2002 Oct; 123(4):1026-30. PubMed ID: 12360464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mutations of the pancreatic secretory trypsin inhibitor. Is the cause of chronic pancreatitis now known?].
    Keim V
    Z Gastroenterol; 2001 Aug; 39(8):765-8. PubMed ID: 11558066
    [No Abstract]   [Full Text] [Related]  

  • 28. Motion--genetic testing is useful in the diagnosis of nonhereditary pancreatic conditions: arguments for the motion.
    Whitcomb DC
    Can J Gastroenterol; 2003 Jan; 17(1):47-52. PubMed ID: 12560855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis.
    Kume K; Masamune A; Mizutamari H; Kaneko K; Kikuta K; Satoh M; Satoh K; Kimura K; Suzuki N; Nagasaki Y; Horii A; Shimosegawa T
    Pancreatology; 2005; 5(4-5):354-60. PubMed ID: 15980664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
    Lempinen M; Paju A; Kemppainen E; Smura T; Kylänpää ML; Nevanlinna H; Stenman J; Stenman UH
    Scand J Gastroenterol; 2005 Feb; 40(2):225-30. PubMed ID: 15764155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
    Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of physiological stress conditions on protein structure and trypsin inhibition of serine protease inhibitor Kazal type 1 (SPINK1) and its N34S variant.
    Buchholz I; Nagel F; Klein A; Wagh PR; Mahajan UM; Greinacher A; Lerch MM; Mayerle J; Delcea M
    Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140281. PubMed ID: 31525466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.
    Bhatia E; Choudhuri G; Sikora SS; Landt O; Kage A; Becker M; Witt H
    Gastroenterology; 2002 Oct; 123(4):1020-5. PubMed ID: 12360463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
    Keiles S; Kammesheidt A
    Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic prevalence and characteristics in children with recurrent pancreatitis.
    Sultan M; Werlin S; Venkatasubramani N
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):645-50. PubMed ID: 22094894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serine protease inhibitor kazal type 1 mutations and pancreatitis.
    Schneider A
    Clin Lab Med; 2005 Mar; 25(1):61-78. PubMed ID: 15749232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare hereditary cause of chronic pancreatitis in a young male: SPINK1 mutation.
    Patel J; Madan A; Gammon A; Sossenheimer M; Samadder NJ
    Pan Afr Med J; 2017; 28():110. PubMed ID: 29515728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
    Ellis I
    Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do point mutations in the PSTI (SPINK1) gene truly contribute to the pathogenesis of chronic pancreatitis?
    Shimosegawa T
    J Gastroenterol; 2001 Sep; 36(9):645-7. PubMed ID: 11578072
    [No Abstract]   [Full Text] [Related]  

  • 40. Mutations in the calcium-sensing receptor: a new genetic risk factor for chronic pancreatitis?
    Felderbauer P; Klein W; Bulut K; Ansorge N; Dekomien G; Werner I; Epplen JT; Schmitz F; Schmidt WE
    Scand J Gastroenterol; 2006 Mar; 41(3):343-8. PubMed ID: 16497624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.